-
1
-
-
0141789642
-
Candida albicans secreted aspartyl proteinases in virulence and pathogenesis
-
Naglik JR, Challacombe SJ, Hube B. Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Microbiol Mol Biol Rev 2003;67:400-428.
-
(2003)
Microbiol Mol Biol Rev
, vol.67
, pp. 400-428
-
-
Naglik, J.R.1
Challacombe, S.J.2
Hube, B.3
-
2
-
-
33644683261
-
Hydrolytic enzymes as virulence factors of Candida albicans
-
Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005;48:365-377.
-
(2005)
Mycoses
, vol.48
, pp. 365-377
-
-
Schaller, M.1
Borelli, C.2
Korting, H.C.3
Hube, B.4
-
3
-
-
0033018944
-
In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients
-
Schaller M, Hube B, Ollert MW, Schafer W, Borg-von Zepelin M, Thoma-Greber E, Korting HC. In vivo expression and localization of Candida albicans secreted aspartyl proteinases during oral candidiasis in HIV-infected patients. J Invest Dermatol 1999;112:383-386.
-
(1999)
J Invest Dermatol
, vol.112
, pp. 383-386
-
-
Schaller, M.1
Hube, B.2
Ollert, M.W.3
Schafer, W.4
Borg-von Zepelin, M.5
Thoma-Greber, E.6
Korting, H.C.7
-
4
-
-
0030884478
-
Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence
-
Hube B, Sanglard D, Odds FC, Hess D, Monod M, Schafer W, Brown AJ, Gow NA. Disruption of each of the secreted aspartyl proteinase genes SAP1, SAP2, and SAP3 of Candida albicans attenuates virulence Infect Immun 1997;65:3529-3538.
-
(1997)
Infect Immun
, vol.65
, pp. 3529-3538
-
-
Hube, B.1
Sanglard, D.2
Odds, F.C.3
Hess, D.4
Monod, M.5
Schafer, W.6
Brown, A.J.7
Gow, N.A.8
-
5
-
-
0030884697
-
A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence
-
Sanglard D, Hube B, Monod M, Odds FC, Gow NA. A triple deletion of the secreted aspartyl proteinase genes SAP4, SAP5, and SAP6 of Candida albicans causes attenuated virulence. Infect Immun 1997;65:3539-3546.
-
(1997)
Infect Immun
, vol.65
, pp. 3539-3546
-
-
Sanglard, D.1
Hube, B.2
Monod, M.3
Odds, F.C.4
Gow, N.A.5
-
6
-
-
0034929770
-
Candida proteases and their inhibition: Prospects for antifungal therapy
-
Stewart K, Abad-Zapatero C. Candida proteases and their inhibition: prospects for antifungal therapy. Curr Med Chem 2001;8:941-948.
-
(2001)
Curr Med Chem
, vol.8
, pp. 941-948
-
-
Stewart, K.1
Abad-Zapatero, C.2
-
8
-
-
0032900510
-
In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis
-
Naglik JR, Newport G, White TC, Fernandes-Naglik LL, Greenspan JS, Greenspan D, Sweet SP, Challacombe SJ, Agabian N. In vivo analysis of secreted aspartyl proteinase expression in human oral candidiasis. Infect Immun 1999;67:2482-2490.
-
(1999)
Infect Immun
, vol.67
, pp. 2482-2490
-
-
Naglik, J.R.1
Newport, G.2
White, T.C.3
Fernandes-Naglik, L.L.4
Greenspan, J.S.5
Greenspan, D.6
Sweet, S.P.7
Challacombe, S.J.8
Agabian, N.9
-
9
-
-
0034923216
-
Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo
-
Schaller M, Januschke E, Schackert C, Woerle B, Korting HC. Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. J Med Microbiol 2001;50:743-747.
-
(2001)
J Med Microbiol
, vol.50
, pp. 743-747
-
-
Schaller, M.1
Januschke, E.2
Schackert, C.3
Woerle, B.4
Korting, H.C.5
-
10
-
-
33644861572
-
Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions
-
Albrecht A, Felk A, Pichova I, Naglik JR, Schaller M, de Groot P, Maccallum D, Odds FC, Schafer W, Klis F, Monod M, Hube B. Glycosylphosphatidylinositol-anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem 2006;281:688-694.
-
(2006)
J Biol Chem
, vol.281
, pp. 688-694
-
-
Albrecht, A.1
Felk, A.2
Pichova, I.3
Naglik, J.R.4
Schaller, M.5
de Groot, P.6
Maccallum, D.7
Odds, F.C.8
Schafer, W.9
Klis, F.10
Monod, M.11
Hube, B.12
-
11
-
-
0032722557
-
Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection
-
Kvaal C, Lachke SA, Srikantha T, Daniels K, McCoy J, Soll DR. Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. Infect Immun 1999;67:6652-6662.
-
(1999)
Infect Immun
, vol.67
, pp. 6652-6662
-
-
Kvaal, C.1
Lachke, S.A.2
Srikantha, T.3
Daniels, K.4
McCoy, J.5
Soll, D.R.6
-
12
-
-
34248370072
-
Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p
-
Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun 2007;75:2126-2135.
-
(2007)
Infect Immun
, vol.75
, pp. 2126-2135
-
-
Villar, C.C.1
Kashleva, H.2
Nobile, C.J.3
Mitchell, A.P.4
Dongari-Bagtzoglou, A.5
-
13
-
-
0025032294
-
Modulation of experimental systemic murine candidosis by intravenous pepstatin
-
Ruchel R, Ritter B, Schaffrinski M. Modulation of experimental systemic murine candidosis by intravenous pepstatin. Zentralbl Bakteriol 1990;273:391-403.
-
(1990)
Zentralbl Bakteriol
, vol.273
, pp. 391-403
-
-
Ruchel, R.1
Ritter, B.2
Schaffrinski, M.3
-
14
-
-
0031037510
-
Role of aspartic proteases in disseminated Candida albicans infection in mice
-
Fallon K, Bausch K, Noonan J, Huguenel E, Tamburini P. Role of aspartic proteases in disseminated Candida albicans infection in mice. Infect Immun 1997;65:551-556.
-
(1997)
Infect Immun
, vol.65
, pp. 551-556
-
-
Fallon, K.1
Bausch, K.2
Noonan, J.3
Huguenel, E.4
Tamburini, P.5
-
15
-
-
0030310227
-
Candida albicans secreted aspartyl proteinases
-
Hube B. Candida albicans secreted aspartyl proteinases. Curr Top Med Mycol 1996;7:55-69.
-
(1996)
Curr Top Med Mycol
, vol.7
, pp. 55-69
-
-
Hube, B.1
-
16
-
-
0026680191
-
Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase
-
Capobianco JO, Lerner CG, Goldman RC. Application of a fluorogenic substrate in the assay of proteolytic activity and in the discovery of a potent inhibitor of Candida albicans aspartic proteinase. Anal Biochem 1992;204:96-102.
-
(1992)
Anal Biochem
, vol.204
, pp. 96-102
-
-
Capobianco, J.O.1
Lerner, C.G.2
Goldman, R.C.3
-
17
-
-
0034648004
-
Enzymic characteristics of secreted aspartic proteases of Candida albicans
-
Koelsch G, Tang J, Loy JA, Monod M, Jackson K, Foundling SI, Lin X. Enzymic characteristics of secreted aspartic proteases of Candida albicans. Biochim Biophys Acta 2000;1480:117-131.
-
(2000)
Biochim Biophys Acta
, vol.1480
, pp. 117-131
-
-
Koelsch, G.1
Tang, J.2
Loy, J.A.3
Monod, M.4
Jackson, K.5
Foundling, S.I.6
Lin, X.7
-
18
-
-
0037080207
-
Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects
-
Cassone A, Tacconelli E, De Bernardis F, Tumbarello M, Torosantucci A, Chiani P, Cauda R. Antiretroviral therapy with protease inhibitors has an early, immune reconstitution-independent beneficial effect on Candida virulence and oral candidiasis in human immunodeficiency virus-infected subjects. J Infect Dis 2002;185:188-195.
-
(2002)
J Infect Dis
, vol.185
, pp. 188-195
-
-
Cassone, A.1
Tacconelli, E.2
De Bernardis, F.3
Tumbarello, M.4
Torosantucci, A.5
Chiani, P.6
Cauda, R.7
-
19
-
-
0032873005
-
Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients
-
Korting HC, Schaller M, Eder G, Hamm G, Bohmer U, Hube B. Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients. Antimicrob Agents Chemother 1999;43:2038-2042.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, pp. 2038-2042
-
-
Korting, H.C.1
Schaller, M.2
Eder, G.3
Hamm, G.4
Bohmer, U.5
Hube, B.6
-
20
-
-
0034844346
-
Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors
-
Pichova I, Pavlickova L, Dostal J, Dolejsi E, Hruskova-Heidingsfeldova O, Weber J, Ruml T, Soucek M. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. Eur J Biochem 2001;268:2669-2677.
-
(2001)
Eur J Biochem
, vol.268
, pp. 2669-2677
-
-
Pichova, I.1
Pavlickova, L.2
Dostal, J.3
Dolejsi, E.4
Hruskova-Heidingsfeldova, O.5
Weber, J.6
Ruml, T.7
Soucek, M.8
-
21
-
-
0032768787
-
The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors
-
Monod M, Borg-von Zepelin M, Telenti A, Sanglard D. The inhibition of Candida-albicans-secreted aspartic proteases by three different HIV protease inhibitors. Dermatology 1999;198:412-414.
-
(1999)
Dermatology
, vol.198
, pp. 412-414
-
-
Monod, M.1
Borg-von Zepelin, M.2
Telenti, A.3
Sanglard, D.4
-
22
-
-
33644960748
-
Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans
-
Backman D, Monod M, Danielson UH. Biosensor-based screening and characterization of HIV-1 inhibitor interactions with Sap 1, Sap 2, and Sap 3 from Candida albicans. J Biomol Screen 2006;11:165-175.
-
(2006)
J Biomol Screen
, vol.11
, pp. 165-175
-
-
Backman, D.1
Monod, M.2
Danielson, U.H.3
-
23
-
-
0035135762
-
New developments in medical mycology
-
Korting HC, Schaller M. New developments in medical mycology. Hautarzt 2001;52:91-97.
-
(2001)
Hautarzt
, vol.52
, pp. 91-97
-
-
Korting, H.C.1
Schaller, M.2
-
24
-
-
0035993392
-
The secreted aspartic proteinases as a new target in the therapy of candidiasis
-
Bein M, Schaller M, Korting HC. The secreted aspartic proteinases as a new target in the therapy of candidiasis. Curr Drug Targets 2002;3:351-357.
-
(2002)
Curr Drug Targets
, vol.3
, pp. 351-357
-
-
Bein, M.1
Schaller, M.2
Korting, H.C.3
-
25
-
-
0029998914
-
The role of Candida albicans secreted aspartic proteinase in the development of candidoses
-
Hoegl L, Ollert M, Korting HC. The role of Candida albicans secreted aspartic proteinase in the development of candidoses. J Mol Med 1996;74:135-142.
-
(1996)
J Mol Med
, vol.74
, pp. 135-142
-
-
Hoegl, L.1
Ollert, M.2
Korting, H.C.3
-
26
-
-
0029935527
-
Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents
-
Abad-Zapatero C, Goldman R, Muchmore SW, Hutchins C, Stewart K, Navaza J, Payne CD, Ray TL. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: implications for the design of antifungal agents. Protein Sci 1996;5:640-652.
-
(1996)
Protein Sci
, vol.5
, pp. 640-652
-
-
Abad-Zapatero, C.1
Goldman, R.2
Muchmore, S.W.3
Hutchins, C.4
Stewart, K.5
Navaza, J.6
Payne, C.D.7
Ray, T.L.8
-
27
-
-
0029645880
-
The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors
-
Cutfield SM, Dodson EJ, Anderson BF, Moody PC, Marshall CJ, Sullivan PA, Cutfield JF. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. Structure 1995;3:1261-1271.
-
(1995)
Structure
, vol.3
, pp. 1261-1271
-
-
Cutfield, S.M.1
Dodson, E.J.2
Anderson, B.F.3
Moody, P.C.4
Marshall, C.J.5
Sullivan, P.A.6
Cutfield, J.F.7
-
28
-
-
34447525518
-
The crystal structure of the secreted aspartic proteinase (Sap) 3 from Candida albicans and its complex with pepstatin A. Proteins: Struct Funct
-
Borelli C, Ruge E, Schaller M, Monod M, Korting HC, Huber R, Maskos K. The crystal structure of the secreted aspartic proteinase (Sap) 3 from Candida albicans and its complex with pepstatin A. Proteins: Struct Funct Bioinformatics 2007;68:738-748.
-
(2007)
Bioinformatics
, vol.68
, pp. 738-748
-
-
Borelli, C.1
Ruge, E.2
Schaller, M.3
Monod, M.4
Korting, H.C.5
Huber, R.6
Maskos, K.7
-
29
-
-
0031971193
-
The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages
-
Borg-von Zepelin M, Beggah S, Boggian K, Sanglard D, Monod M. The expression of the secreted aspartyl proteinases Sap4 to Sap6 from Candida albicans in murine macrophages. Mol Microbiol 1998;28:543-554.
-
(1998)
Mol Microbiol
, vol.28
, pp. 543-554
-
-
Borg-von Zepelin, M.1
Beggah, S.2
Boggian, K.3
Sanglard, D.4
Monod, M.5
-
30
-
-
0014949207
-
Cleavage of structural proteins during the assembly of the head of bacteriophage T4
-
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
-
(1970)
Nature
, vol.227
, pp. 680-685
-
-
Laemmli, U.K.1
-
31
-
-
0031059866
-
Macromolecular crystallography
-
Carter CW, Sweet RM, editors, London: Academic Press;
-
Otwinowski Z, Minor W. Macromolecular crystallography. In: Carter CW, Sweet RM, editors. Methods in enzymology, Vol. 276. London: Academic Press; 1997. p 307.
-
(1997)
Methods in enzymology
, vol.276
, pp. 307
-
-
Otwinowski, Z.1
Minor, W.2
-
34
-
-
3543012707
-
Crystallography and NMR system: A new software suite for macromolecular structure determination
-
Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL. Crystallography and NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 1998;54(Part 5):905-921.
-
(1998)
Acta Crystallogr D Biol Crystallogr
, vol.54
, Issue.PART 5
, pp. 905-921
-
-
Brunger, A.T.1
Adams, P.D.2
Clore, G.M.3
DeLano, W.L.4
Gros, P.5
Grosse-Kunstleve, R.W.6
Jiang, J.S.7
Kuszewski, J.8
Nilges, M.9
Pannu, N.S.10
Read, R.J.11
Rice, L.M.12
Simonson, T.13
Warren, G.L.14
-
38
-
-
0027968068
-
CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
-
Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673-4680.
-
(1994)
Nucleic Acids Res
, vol.22
, pp. 4673-4680
-
-
Thompson, J.D.1
Higgins, D.G.2
Gibson, T.J.3
-
39
-
-
0026319199
-
Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons
-
Nicholls A, Sharp KA, Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 1991;11:281-296.
-
(1991)
Proteins
, vol.11
, pp. 281-296
-
-
Nicholls, A.1
Sharp, K.A.2
Honig, B.3
-
40
-
-
0027940569
-
Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans
-
Hube B, Monod M, Schofield DA, Brown AJ, Gow NA. Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 1994;14:87-99.
-
(1994)
Mol Microbiol
, vol.14
, pp. 87-99
-
-
Hube, B.1
Monod, M.2
Schofield, D.A.3
Brown, A.J.4
Gow, N.A.5
-
41
-
-
0029128928
-
Candida albicans secreted aspartyl proteinases: Isoenzyme pattern is determined by cell type, and levels are determined by environmental factors
-
White TC, Agabian N. Candida albicans secreted aspartyl proteinases: isoenzyme pattern is determined by cell type, and levels are determined by environmental factors. J Bacteriol 1995;177:5215-5221.
-
(1995)
J Bacteriol
, vol.177
, pp. 5215-5221
-
-
White, T.C.1
Agabian, N.2
-
42
-
-
0025290527
-
The structure and function of the aspartic proteinases
-
Davies DR. The structure and function of the aspartic proteinases. Annu Rev Biophys Biophys Chem 1990;19:189-215.
-
(1990)
Annu Rev Biophys Biophys Chem
, vol.19
, pp. 189-215
-
-
Davies, D.R.1
-
43
-
-
0026720426
-
Crystallographic analysis of transition state mimics bound to penicillopepsin: Difluorostatine- and difluorostatone-containing peptides
-
James MN, Sielecki AR, Hayakawa K, Gelb MH. Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. Biochemistry 1992;31:3872-3886.
-
(1992)
Biochemistry
, vol.31
, pp. 3872-3886
-
-
James, M.N.1
Sielecki, A.R.2
Hayakawa, K.3
Gelb, M.H.4
-
44
-
-
0026760269
-
Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes
-
Parris KD, Hoover DJ, Damon DB, Davies DR. Synthesis and crystallographic analysis of two rhizopuspepsin inhibitor complexes. Biochemistry 1992;31:8125-8141.
-
(1992)
Biochemistry
, vol.31
, pp. 8125-8141
-
-
Parris, K.D.1
Hoover, D.J.2
Damon, D.B.3
Davies, D.R.4
-
45
-
-
0023434194
-
Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: Implications for a mechanism of action
-
Suguna K, Padlan EA, Smith CW, Carlson WD, Davies DR. Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. Proc Natl Acad Sci USA 1987;84:7009-7013.
-
(1987)
Proc Natl Acad Sci USA
, vol.84
, pp. 7009-7013
-
-
Suguna, K.1
Padlan, E.A.2
Smith, C.W.3
Carlson, W.D.4
Davies, D.R.5
-
46
-
-
0027050188
-
Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases
-
Veerapandian B, Cooper JB, Sali A, Blundell TL, Rosati RL, Dominy BW, Damon DB, Hoover DJ. Direct observation by X-ray analysis of the tetrahedral "intermediate" of aspartic proteinases. Protein Sci 1992;1:322-328.
-
(1992)
Protein Sci
, vol.1
, pp. 322-328
-
-
Veerapandian, B.1
Cooper, J.B.2
Sali, A.3
Blundell, T.L.4
Rosati, R.L.5
Dominy, B.W.6
Damon, D.B.7
Hoover, D.J.8
-
47
-
-
0035188306
-
Analysis of crystal structures of aspartic proteinases: On the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes
-
Andreeva NS, Rumsh LD. Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes. Protein Sci 2001;10:2439-2450.
-
(2001)
Protein Sci
, vol.10
, pp. 2439-2450
-
-
Andreeva, N.S.1
Rumsh, L.D.2
-
48
-
-
0016914760
-
The mechanism of the catalytic action of pepsin and related acid proteinases
-
Fruton JS. The mechanism of the catalytic action of pepsin and related acid proteinases. Adv Enzymol Relat Areas Mol Biol 1976;44:1-36.
-
(1976)
Adv Enzymol Relat Areas Mol Biol
, vol.44
, pp. 1-36
-
-
Fruton, J.S.1
-
49
-
-
0028919869
-
Engineering the substrate specificity of rhizopuspepsin: The role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in Pl
-
Lowther WT, Majer P, Dunn BM. Engineering the substrate specificity of rhizopuspepsin: the role of Asp 77 of fungal aspartic proteinases in facilitating the cleavage of oligopeptide substrates with lysine in Pl. Protein Sci 1995;4:689-702.
-
(1995)
Protein Sci
, vol.4
, pp. 689-702
-
-
Lowther, W.T.1
Majer, P.2
Dunn, B.M.3
-
50
-
-
0027414640
-
Two crystal structures for cathepsin D: The lysosomal targeting signal and active site
-
Metcalf P, Fusek M. Two crystal structures for cathepsin D: the lysosomal targeting signal and active site. EMBO J 1993;12:1293-1302.
-
(1993)
EMBO J
, vol.12
, pp. 1293-1302
-
-
Metcalf, P.1
Fusek, M.2
-
51
-
-
0000906630
-
Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin
-
James MN, Sielecki A, Salituro F, Rich DH, Hofmann T. Conformational flexibility in the active sites of aspartyl proteinases revealed by a pepstatin fragment binding to penicillopepsin. Proc Natl Acad Sci USA 1982;79:6137-6141.
-
(1982)
Proc Natl Acad Sci USA
, vol.79
, pp. 6137-6141
-
-
James, M.N.1
Sielecki, A.2
Salituro, F.3
Rich, D.H.4
Hofmann, T.5
-
52
-
-
0026693512
-
Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors
-
Suguna K, Padlan EA, Bott R, Boger J, Parris KD, Davies DR. Structures of complexes of rhizopuspepsin with pepstatin and other statine-containing inhibitors. Proteins 1992;13:195-205.
-
(1992)
Proteins
, vol.13
, pp. 195-205
-
-
Suguna, K.1
Padlan, E.A.2
Bott, R.3
Boger, J.4
Parris, K.D.5
Davies, D.R.6
-
53
-
-
0028933321
-
Crystal structure of human pepsin and its complex with pepstatin
-
Fujinaga M, Chernaia MM, Tarasova NI, Mosimann SC, James MN. Crystal structure of human pepsin and its complex with pepstatin. Protein Sci 1995;4:960-972.
-
(1995)
Protein Sci
, vol.4
, pp. 960-972
-
-
Fujinaga, M.1
Chernaia, M.M.2
Tarasova, N.I.3
Mosimann, S.C.4
James, M.N.5
-
54
-
-
0024492495
-
Crystal structure of a retroviral protease proves relationship to aspartic protease family
-
Miller M, Jaskolski M, Rao JK, Leis J, Wlodawer A. Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature 1989;337:576-579.
-
(1989)
Nature
, vol.337
, pp. 576-579
-
-
Miller, M.1
Jaskolski, M.2
Rao, J.K.3
Leis, J.4
Wlodawer, A.5
-
55
-
-
0024581802
-
Molecular modeling of the HIV-1 protease and its substrate binding site
-
Weber IT, Miller M, Jaskolski M, Leis J, Skalka AM, Wlodawer A. Molecular modeling of the HIV-1 protease and its substrate binding site. Science 1989;243:928-931.
-
(1989)
Science
, vol.243
, pp. 928-931
-
-
Weber, I.T.1
Miller, M.2
Jaskolski, M.3
Leis, J.4
Skalka, A.M.5
Wlodawer, A.6
-
56
-
-
0028968902
-
ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans
-
Kempf DJ, Marsh KC, Denissen JF, McDonald E, Vasavanonda S, Flentge CA, Green BE, Fino L, Park CH, Kong XP, Wideburg NE, Saldivar A, Ruiz L, Kati WM, Sham HL, Robins T, Stewart KD, Hsu A, Plattner JJ, Leonard JM, Norbeck DW ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans. Proc Natl Acad Sci USA 1995;92:2484-2488.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 2484-2488
-
-
Kempf, D.J.1
Marsh, K.C.2
Denissen, J.F.3
McDonald, E.4
Vasavanonda, S.5
Flentge, C.A.6
Green, B.E.7
Fino, L.8
Park, C.H.9
Kong, X.P.10
Wideburg, N.E.11
Saldivar, A.12
Ruiz, L.13
Kati, W.M.14
Sham, H.L.15
Robins, T.16
Stewart, K.D.17
Hsu, A.18
Plattner, J.J.19
Leonard, J.M.20
Norbeck, D.W.21
more..
|